BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36455864)

  • 21. High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue Sarcoma.
    Traweek RS; Lyu HG; Witt RG; Snyder RA; Nassif EF; Krijgh DD; Smith JM; Tilney GS; Feng C; Chiang YJ; Torres KE; Roubaud MJ; Scally CP; Hunt KK; Keung EZ; Mericli AF; Roland CL
    Ann Surg Oncol; 2024 Jun; 31(6):4138-4147. PubMed ID: 38396039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comorbidity indexing for prediction of the clinical outcome after stereotactic body radiation therapy in non-small cell lung cancer.
    Dreyer J; Bremer M; Henkenberens C
    Radiat Oncol; 2018 Nov; 13(1):213. PubMed ID: 30390700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-adjusted Charlson comorbidity index in recurrent glioblastoma: a new prognostic factor?
    Barz M; Bette S; Janssen I; Aftahy AK; Huber T; Liesche-Starnecker F; Ryang YM; Wiestler B; Combs SE; Meyer B; Gempt J
    BMC Neurol; 2022 Jan; 22(1):32. PubMed ID: 35062885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic significance of margin width for extremity and trunk sarcoma.
    McKee MD; Liu DF; Brooks JJ; Gibbs JF; Driscoll DL; Kraybill WG
    J Surg Oncol; 2004 Feb; 85(2):68-76. PubMed ID: 14755506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer.
    Suidan RS; Leitao MM; Zivanovic O; Gardner GJ; Long Roche KC; Sonoda Y; Levine DA; Jewell EL; Brown CL; Abu-Rustum NR; Charlson ME; Chi DS
    Gynecol Oncol; 2015 Aug; 138(2):246-51. PubMed ID: 26037900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centres.
    Smolle MA; van de Sande M; Hayes A; Bergovec M; Smith HG; Liegl-Atzwanger B; Tunn PU; Niethard M; Windhager R; Szkandera J; Leithner A
    Eur J Surg Oncol; 2021 Aug; 47(8):2182-2188. PubMed ID: 33865657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Prognostic Value of Lymphovascular Invasion in Truncal and Extremity Soft Tissue Sarcomas: An Analysis from the National Cancer Database.
    Ethun CG; Lopez-Aguiar AG; Switchenko JM; Gillespie TW; Delman KA; Staley CA; Maithel SK; Cardona K
    Ann Surg Oncol; 2019 Dec; 26(13):4723-4729. PubMed ID: 31502023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors for local recurrence and mortality in adult soft tissue sarcoma of the extremities and trunk wall: a cohort study of 922 consecutive patients.
    Maretty-Nielsen K; Aggerholm-Pedersen N; Safwat A; Jørgensen PH; Hansen BH; Baerentzen S; Pedersen AB; Keller J
    Acta Orthop; 2014 Jun; 85(3):323-32. PubMed ID: 24694277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables.
    Stojadinovic A; Leung DH; Allen P; Lewis JJ; Jaques DP; Brennan MF
    J Clin Oncol; 2002 Nov; 20(21):4344-52. PubMed ID: 12409334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors in soft tissue sarcoma.
    Maretty-Nielsen K
    Dan Med J; 2014 Nov; 61(11):B4957. PubMed ID: 25370967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of patients with soft tissue sarcomas of the extremities and trunk treated by (neo)adjuvant intensity modulated radiation therapy with curative intent.
    Dapper H; Diehl C; Knebel C; Mogler C; Borm K; Dobiasch S; Combs SE; Peeken JC
    Radiat Oncol; 2023 Mar; 18(1):44. PubMed ID: 36869396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
    Pasquali S; Pizzamiglio S; Touati N; Litiere S; Marreaud S; Kasper B; Gelderblom H; Stacchiotti S; Judson I; Dei Tos AP; Verderio P; Casali PG; Woll PJ; Gronchi A;
    Eur J Cancer; 2019 Mar; 109():51-60. PubMed ID: 30690293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comorbidity is independently associated with poor outcome in extremity soft tissue sarcoma.
    Kang S; Kim HS; Kim W; Kim JH; Kang SH; Han I
    Clin Orthop Surg; 2015 Mar; 7(1):120-30. PubMed ID: 25729528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a model based on the age-adjusted Charlson comorbidity index to predict survival for resected perihilar cholangiocarcinoma.
    Pan Y; Liu ZP; Dai HS; Chen WY; Luo Y; Wang YZ; Gao SY; Wang ZR; Dong JL; Liu YH; Yin XY; Liu XC; Fan HN; Bai J; Jiang Y; Cheng JJ; Zhang YQ; Chen ZY
    World J Gastrointest Oncol; 2023 Jun; 15(6):1036-1050. PubMed ID: 37389112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of comorbidities in patients with carcinoma of the major salivary glands.
    Becker C; Dahlem KKK; Pfeiffer J
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1651-1657. PubMed ID: 27888340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival in primary soft tissue sarcoma of the extremities and trunk.
    Peiper M; Zurakowski D; Zornig C
    Langenbecks Arch Chir; 1997; 382(4):203-8. PubMed ID: 9396000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma.
    Park G; Song SY; Ahn JH; Kim WL; Lee JS; Jeong SY; Park JW; Choi EK; Choi W; Jung IH
    Radiat Oncol; 2019 Jul; 14(1):116. PubMed ID: 31272506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-adjusted Charlson Comorbidity Index predicts prognosis of laryngopharyngeal cancer treated with radiation therapy.
    Takemura K; Takenaka Y; Ashida N; Shimizu K; Oya R; Kitamura T; Yamamoto Y; Uno A
    Acta Otolaryngol; 2017 Dec; 137(12):1307-1312. PubMed ID: 28875745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment and analysis of prognostic factors of stage Ⅱ and Ⅲ undifferentiated high-grade pleomorphic sarcoma in extremities and trunk].
    Zhang XX; Xu LB; Xu SF; Zhao ZG; Fang H; Ma PQ; Liu T; Zhang SG; Yu SJ
    Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):140-145. PubMed ID: 30862145
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical significance of preoperative serum high density lipoprotein cholesterol levels in soft tissue sarcoma.
    Que Y; Jiang F; Liu L; Li Y; Chen Y; Qiu H; Zhou Z; Zhang X
    Medicine (Baltimore); 2015 May; 94(18):e844. PubMed ID: 25950696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.